Concepedia

The tyrosine kinase inhibitor dasatinib effectively blocks PDGF-induced orbital fibroblast activation

Sita Virakul, Virgil A. S. H. Dalm, Willem A. van den Bosch, Nattiya Hirankarn, P. Martin van Hagen, Willem A. Dik

Graefe s Archive for Clinical and Experimental Ophthalmology · 2014 · 22 citations · 17 references

DOI

Concepts

References

17

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Hagop M. Kantarjian, Neil P. Shah, Andreas Hochhaus et al. · New England Journal of Medicine · 2010 · 1.6K citations

, , +10

Randomized, Single Blind Trial of Intravenous<i>versus</i>Oral Steroid Monotherapy in Graves’ Orbitopathy

George J. Kahaly, Susanne Pitz, Gerhard Hommel et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 414 citations

, , +14

Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)

Elias Jabbour, Hagop M. Kantarjian, Giuseppe Saglio et al. · Blood · 2013 · 391 citations · Full text

, , +8

Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single Center

Maria Laura Tanda, Eliana Piantanida, Luigi Liparulo et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 323 citations · Full text

, , +15

Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib

T D Kim, Delphine Réa, Michaela Schwarz et al. · Leukemia · 2013 · 233 citations

, , +7